Cell Cycle Deregulation in Cancer

Cell Cycle Deregulation in Cancer
Der Artikel wird am Ende des Bestellprozesses zum Download zur Verfügung gestellt.
 eBook
Sofort lieferbar | Lieferzeit: Sofort lieferbar

213,98 €* eBook

Artikel-Nr:
9781441917706
Veröffentl:
2010
Einband:
eBook
Seiten:
206
Autor:
Greg H. Enders
Serie:
Current Cancer Research
eBook Typ:
PDF
eBook Format:
eBook
Kopierschutz:
Adobe DRM [Hard-DRM]
Sprache:
Englisch
Beschreibung:

Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy.

This collection of 11 reviews shows how cells initiate the cell cycle, describes issues of proliferation, discusses long-term proliferation and relates the uses of cell cycle research in assessment of pre-malignant states and in cancer therapy.

Cancer is fundamentally a disease of abnormal cell proliferation: Cancer cells multiply when and where they should not. This proliferation entails escape from normal bounds imposed by the tissue environment, the internal biology of the cell (DNA damage, chromosomal imbalances, disorganized mitotic spindles), and the proliferative history of the cell (normal generational times). Some of the key oncogenic events in cancer directly perturb proteins that regulate progression through the cell division cycle, others alter cell cycle progression indirectly, through effects on signaling pathway that impinge on the cell cycle. This biology is fundamentally important in cancer therapy. Many of the workhorse treatments for cancer rely on killing proliferating cells. Furthermore, there is growing recognition that stem cell-transit amplifying cell hierarchies may persist or be generated during tumorigenesis, generating important functional heterogeneity in cell cycle control among tumor cells, with far-reaching scientific and clinical implications. This volume outlines major cell cycle perturbations that drive tumorigenesis and considers the prospects for using such knowledge in cancer therapy.

Starting the cell division cycle Elena Sotillo and Xavier Graña Escape from cellular quiescence Jun-Yuan Ji and Nicholas J. Dyson Interplay between Cyclin-dependent Kinases and E2F-dependent Transcription. A. Kathleen McClendon, Jeffry L. Dean, and Erik S. Knudsen Regulation of pre-RC assembly: A complex symphony orchestrated by CDKs Proliferation under duress Haomin Huang and Timothy J Yen Mitotic checkpoint and chromosome instability in cancer Jeremy P.H. Chow and Randy Y.C. Poon Mitotic catastrophe Robert D. Hontz and Maureen E. Murphy p53, ARF and the control of autophagy Long-term proliferation Andrea Viale and Pier Giuseppe Pelicci Regulation of self-renewing divisions in normal and leukaemia stem cells Eros Lazzerini Denchi Maintenance of Telomeres in Cancer Peter D. Adams The senescence secretome and its impact on tumor suppression and cancer Applications in preventing and treating cancer Pierre Lao-Sirieix and Rebecca C Fitzgerald Cell cycle deregulation in pre-neoplasia: case study of Barrett’s esophagus Neil Johnson and Geoffrey I. Shapiro Targeting cyclin dependent kinases for cancer therapy

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.